Zobrazeno 1 - 10
of 218
pro vyhledávání: '"M. Gamper"'
Publikováno v:
Geographica Helvetica, Vol 33, Iss 4, Pp 183-189
No abstract available.
Externí odkaz:
https://doaj.org/article/6c800f9d568b4531af51ca70a3812d97
Publikováno v:
Geographica Helvetica, Vol 42, Iss 2, Pp 61-91
A Statistical analysis of published and compilated snowline data for the late-glacial Stades of Gschnitz, Clavadel, Daun and Egesen is presented. The calculation of snowline and snowline-depression (compared to the extent of 1850) is based on the 2:
Externí odkaz:
https://doaj.org/article/861b37fe9af746958e8588b2ecffd375
Publikováno v:
Geographica Helvetica, Vol 37, Iss 2, Pp 105-114
No abstract available.
Externí odkaz:
https://doaj.org/article/72219e90116346a99a674d08a3c44ba8
Autor:
Hitt, Quinn T. Storozynsky, Xuefei Han, Shae Komant, Kate C. Agopsowicz, Kyle G. Potts, Armin M. Gamper, Roseline Godbout, David H. Evans, Mary M.
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3341
Glioblastoma (GBM) is a malignant brain cancer refractory to the current standard of care, prompting an extensive search for novel strategies to improve outcomes. One approach under investigation is oncolytic virus (OV) therapy in combination with ra
Autor:
Jiesi Zhou, Yan Shu Kong, Krista M. Vincent, Dylan Dieters‐Castator, Amirali B. Bukhari, Darryl Glubrecht, Rong‐Zong Liu, Douglas Quilty, Scott D. Findlay, Xiaowei Huang, Zhihua Xu, Rui Zhe Yang, Lanyue Zhang, Emily Tang, Gilles Lajoie, David D. Eisenstat, Armin M. Gamper, Richard Fahlman, Roseline Godbout, Lynne‐Marie Postovit, YangXin Fu
Publikováno v:
Molecular Oncology.
Autor:
Gordon K. Chan, Armin M. Gamper, Shelagh D. Campbell, John R. Mackey, Ellen Homola, Joanne D. Smith, Won-Shik Choi, Edric J. Xiao, Amirali B. Bukhari, Cody W. Lewis
suppl figures 1-6. SF1: Myt1 knockdown sensitizes breast cells to Adavosertib; SF2: Wee1 knockdown mimics Adavosertib treatment; SF3: Adavosertib does not inhibit Myt1 activity; SF4: Adavosertib resistant cells do not prematurely enter mitosis; SF5:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4f4c17ce52979bc6a099cf2f397488
https://doi.org/10.1158/0008-5472.22421838
https://doi.org/10.1158/0008-5472.22421838
Autor:
Gordon K. Chan, Armin M. Gamper, Shelagh D. Campbell, John R. Mackey, Ellen Homola, Joanne D. Smith, Won-Shik Choi, Edric J. Xiao, Amirali B. Bukhari, Cody W. Lewis
Adavosertib (also known as AZD1775 or MK1775) is a small-molecule inhibitor of the protein kinase Wee1, with single-agent activity in multiple solid tumors, including sarcoma, glioblastoma, and head and neck cancer. Adavosertib also shows promising r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d66b7b25cbd74fb10ecc92c296fc247
https://doi.org/10.1158/0008-5472.c.6511047.v1
https://doi.org/10.1158/0008-5472.c.6511047.v1
Autor:
Jammbe Z. Musoro, Corneel Coens, Mirjam A.G. Sprangers, Yvonne Brandberg, Mogens Groenvold, Hans-Henning Flechtner, Kim Cocks, Galina Velikova, Linda Dirven, Elfriede Greimel, Susanne Singer, Katarzyna Pogoda, Eva M. Gamper, Samantha C. Sodergren, Alexander Eggermont, Michael Koller, Jaap C. Reijneveld, Martin J.B. Taphoorn, Madeleine T. King, Andrew Bottomley
Publikováno v:
Musoro, J Z, Coens, C, Sprangers, M A G, Brandberg, Y, Groenvold, M, Flechtner, H-H, Cocks, K, Velikova, G, Dirven, L, Greimel, E, Singer, S, Pogoda, K, Gamper, E M, Sodergren, S C, Eggermont, A, Koller, M, Reijneveld, J C, Taphoorn, M J B, King, M T & Bottomley, A 2023, ' Minimally important differences for interpreting EORTC QLQ-C30 change scores over time : A synthesis across 21 clinical trials involving nine different cancer types ', European Journal of Cancer, vol. 188, pp. 171-182 . https://doi.org/10.1016/j.ejca.2023.04.027
European Journal of Cancer, 188, 171-182. Pergamon
Musoro, J Z, Coens, C, Sprangers, M A G, Brandberg, Y, Groenvold, M, Flechtner, H-H, Cocks, K, Velikova, G, Dirven, L, Greimel, E, Singer, S, Pogoda, K, Gamper, E M, Sodergren, S C, Eggermont, A, Koller, M, Reijneveld, J C, Taphoorn, M J B, King, M T, Bottomley, A & EORTC Melanoma, Breast, Head and Neck, Genito-urinary, Gynecological, Gastro-intestinal, Brain, Lung and Quality of Life Groups 2023, ' Minimally important differences for interpreting EORTC QLQ-C30 change scores over time : A synthesis across 21 clinical trials involving nine different cancer types ', European journal of cancer (Oxford, England : 1990), vol. 188, pp. 171-182 . https://doi.org/10.1016/j.ejca.2023.04.027
European Journal of Cancer, 188, 171-182. Pergamon
Musoro, J Z, Coens, C, Sprangers, M A G, Brandberg, Y, Groenvold, M, Flechtner, H-H, Cocks, K, Velikova, G, Dirven, L, Greimel, E, Singer, S, Pogoda, K, Gamper, E M, Sodergren, S C, Eggermont, A, Koller, M, Reijneveld, J C, Taphoorn, M J B, King, M T, Bottomley, A & EORTC Melanoma, Breast, Head and Neck, Genito-urinary, Gynecological, Gastro-intestinal, Brain, Lung and Quality of Life Groups 2023, ' Minimally important differences for interpreting EORTC QLQ-C30 change scores over time : A synthesis across 21 clinical trials involving nine different cancer types ', European journal of cancer (Oxford, England : 1990), vol. 188, pp. 171-182 . https://doi.org/10.1016/j.ejca.2023.04.027
Introduction: Early guidelines for minimally important differences (MID) for the EORTC QLQ-C30 proposed ≥10 points change as clinically meaningful for all scales. Increasing evidence that MIDs can vary by scale, direction of change, cancer type and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95198867fe2dd27166ce1545eceb405e
https://doi.org/10.2139/ssrn.4367384
https://doi.org/10.2139/ssrn.4367384
Autor:
Eva M. Gamper, Jammbe Z. Musoro, Corneel Coens, Jean-Jacques Stelmes, Claudette Falato, Mogens Groenvold, Galina Velikova, Kim Cocks, Hans-Henning Flechtner, Madeleine T. King, Andrew Bottomley, on behalf of the EORTC Genito-Urinary Tract Cancer Group and Quality of Life Groups
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
Gamper, E M, Musoro, J Z, Coens, C, Stelmes, J-J, Falato, C, Groenvold, M, Velikova, G, Cocks, K, Flechtner, H-H, King, M T, Bottomley, A & EORTC Genito-Urinary Tract Cancer Group and Quality of Life Groups 2021, ' Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials ', BMC Cancer, vol. 21, no. 1, 1083 . https://doi.org/10.1186/s12885-021-08609-7
BMC Cancer
Gamper, E M, Musoro, J Z, Coens, C, Stelmes, J-J, Falato, C, Groenvold, M, Velikova, G, Cocks, K, Flechtner, H-H, King, M T, Bottomley, A & EORTC Genito-Urinary Tract Cancer Group and Quality of Life Groups 2021, ' Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials ', BMC Cancer, vol. 21, no. 1, 1083 . https://doi.org/10.1186/s12885-021-08609-7
Background The aim of the study was to estimate the minimally important difference (MID) for interpreting group-level change over time, both within a group and between groups, for the European Organisation for Research and Treatment of Cancer Quality
Publikováno v:
64. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V..